Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas Poll is active.

Publication


Featured researches published by Thomas Poll.


Free Radical Research | 1990

17 BETA-ESTRADIOL INHIBITS LDL OXIDATION AND CHOLESTERYL ESTER FORMATION IN CULTURED MACROPHAGES

Lukas Huber; Eckhard Scheffler; Thomas Poll; Reinhard Ziegler; Hans Alois Dresel

The effects of 17 beta estradiol, testosterone, the estradiol benzoate, and probucol on the oxidation kinetics of low density lipoprotein (LDL) in vitro in absorption presence of 10 microM Cu (II) are examined. Changes in the absorption at 234 nm (A234) and fluorescence (Ex340/Em420) are monitored. The kinetics of the changes observed let us suggest a precursor-product relationship between dienes and fluorochromes in the oxidized LDL. The addition of 17 beta estradiol and probucol to LDL results in a prolongation of the lag phase characterized by only insignificant formation of dienes and fluorochromes. The addition of testosterone and estradiol benzoate used as control compounds has no effect on the lag phase and thus no LDL stabilizing effect. Conditioned LDL which was incubated in F-10 medium before exposure to cultured P388D.1 macrophages increases the formation of cytoplasmic lipid droplets and of cellular cholesteryl esters. The LDL stabilizing compounds beta estradiol and probucol (but not testosterone) causes a reduction of the cholesteryl ester content of the cultured macrophages. Protection of LDL particles against oxidative damage apparently results also in lowering of cytoplasmic cholesteryl ester in cultured P388D.1 cells. We conclude that the known antiatherosclerotic potency of 17 beta estradiol may in part result from its LDL stabilizing activity.


Journal of Medicinal Chemistry | 1993

Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity

Alfred Mertens; Harald Zilch; Bernhard Koenig; Wolfgang Schaefer; Thomas Poll; Wolfgang Kampe; Hans Seidel; Ulrike Leser; Herbert Leinert


Structure | 1996

Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design.

Richard A. Engh; Hans Brandstetter; Gudrun Sucher; Andreas Eichinger; Ulrich Baumann; Wolfram Bode; Robert Huber; Thomas Poll; Rainer Rudolph; Wolfgang von der Saal


Archive | 1994

New 4-aminopyridines, process for preparing the same and medicaments containing the same

Der Saal Wolfgang Von; Reinhard Heck; Herbert Leinert; Thomas Poll; Karlheinz Stegmeier; Helmut Michel


Archive | 1994

4-aminopyridines, their production and use as an antithrombosis agent

Herbert Leinert; Der Saal Wolfgang Von; Karlheinz Stegmeier; Thomas Poll


Archive | 1993

Novel 4-alkylaminopyridines - processes for their preparation and medicaments containing these compounds

Reinhard Heck; Herbert Dipl Chem Dr Leinert; Thomas Poll; Der Saal Wolfgang Dipl Che Von; Karlheinz Dipl Chem Stegmeier


Archive | 1992

USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES.

Bernhard König; Ulrike Leser; Alfred Mertens; Wolfgang Schäfer; Thomas Poll


Archive | 1992

Use of oxazolo-[2,3-a]-isoindole and imidazo-[2,1-a]- isoindole derivatives as antiviral medicaments, as well as new oxazolo-[2,3-a]-isoindole derivatives

Bernhard König; Ulrike Leser; Alfred Mertens; Wolfgang Schäfer; Thomas Poll


Archive | 1994

New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds

Reinhard Heck; Herbert Leinert; Thomas Poll; Karlheinz Stegmeier; Der Saal Wolfgang Von; Helmut Michel


Archive | 1992

Use of tricyclic isoindolinones as antiviral drugs, and new, optically active isoindolinones

Harald Zilch; Thomas Poll; Wolfgang Schäfer; Bernhard König; Ulrike Leser

Collaboration


Dive into the Thomas Poll's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge